VACCINES FOR HSV-2
Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Portuguese |
Published |
23.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in either HSV-2 seropositive or seronegative subjects. |
---|---|
Bibliography: | Application Number: PT20130724492T |